Prognostic value of various summary measures of prostate-specific antigen (PSA) kinetics for overall survival (OS) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) who failed first-line chemotherapy (TROPIC trial).

被引：0
|
作者：
Legrand, Catherine
Oudard, Stephane
Sartor, A. Oliver
De Bono, Johann Sebastian
Shen, Liji
Machiels, Jean-Pascal H.
机构：
[1] Catholic Univ Louvain, Inst Stat Biostat & Sci Actuarielles, B-1348 Louvain, Belgium
[2] Georges Pompidou European Hosp, Dept Med Oncol, Paris, France
[3] Tulane Canc Ctr, New Orleans, LA USA
[4] Royal Marsden NHS Fdn Trust, Inst Canc Res, Sutton, Surrey, England
[5] Sanofi Aventis, Malvern, PA USA
[6] Catholic Univ Louvain, Ctr Canc, B-1200 Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16010
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prostate-specific antigen decline (PSA) as a surrogate for overall survival (OS) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) who failed first-line chemotherapy
    Halabi, Susan
    Armstrong, Andrew J.
    Sartor, A. Oliver
    De Bono, Johann Sebastian
    Kaplan, Ellen B.
    Small, Eric Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Kinetics of prostate-specific antigen (PSA) as a marker of abiraterone acetate (AA) efficacy in patients (p) with metastatic castrate-resistant prostate cancer (mCRPC)
    Espana Fernandez, S.
    Piulats, J. M.
    Sala, N.
    Velarde, J. M.
    Ferrandiz, U.
    Etxaniz Ulazia, O.
    Heras Lopez, L.
    Barretina Ginesta, M. P.
    Garcia del Muro, X.
    Font, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] Overall survival (OS) prognostic factors in metastatic castrate-resistant prostate cancer (mCRPC) patients retreated with docetaxel (D)
    Shah, Shilpa Rashmikant
    Albany, Costantine
    Hahn, Noah M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed
    Halabi, Susan
    Lin, Chen-Yen
    Small, Eric Jay
    Armstrong, Andrew J.
    Kaplan, Ellen B.
    Petrylak, Daniel Peter
    Sternberg, Cora N.
    Shen, Liji
    Oudard, Stephane
    De Bono, Johann Sebastian
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [5] Relationship between abiraterone exposure, prostate-specific antigen (PSA) kinetics, and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Xu, Steven
    Ryan, Charles J.
    Stuyckens, Kim
    Smith, Matthew R.
    Saad, Fred
    Griffin, Thomas W.
    Park, Youn Choi
    Yu, Margaret K.
    Vermeulen, An
    Poggesi, Italo
    Nandy, Partha
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [6] A prognostic model for predicting overall survival in metastatic castrate-resistant prostate cancer (mCRPC) men treated with second-line chemotherapy
    Halabi, Susan
    Lin, Chen-Yen
    Small, Eric Jay
    Armstrong, Andrew J.
    Kaplan, Ellen B.
    Petrylak, Daniel Peter
    Sternberg, Cora N.
    Shen, Liji
    Oudard, Stephane
    De Bono, Johann Sebastian
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer
    A G de Liaño
    O Reig
    B Mellado
    C Martin
    E U Rull
    J P Maroto
    British Journal of Cancer, 2014, 110 : 2201 - 2208
  • [8] Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer
    de Liano, A. G.
    Reig, O.
    Mellado, B.
    Martin, C.
    Rull, E. U.
    Maroto, J. P.
    BRITISH JOURNAL OF CANCER, 2014, 110 (09) : 2201 - 2208
  • [9] Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer
    Schiff, Joshua P.
    Cotogno, Patrick
    Feibus, Allison
    Steinwald, Peter
    Ledet, Elisa
    Lewis, Brian
    Sartor, Oliver
    BMC CANCER, 2019, 19 (1)
  • [10] Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer
    Joshua P. Schiff
    Patrick Cotogno
    Allison Feibus
    Peter Steinwald
    Elisa Ledet
    Brian Lewis
    Oliver Sartor
    BMC Cancer, 19
12345